Fig. 1From: Adjuvant stereotactic fractionated radiotherapy to the resection cavity in recurrent glioblastoma – the GlioCave study (NOA 17 – ARO 2016/3 – DKTK ROG trial)Flow chart of the GlioCave/NOA-17-TrialBack to article page